State of New Jersey Common Pension Fund D’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-33,199
| Closed | -$4.38M | – | 1529 |
|
|
2025
Q1 | $4.38M | Sell |
33,199
-3,623
| -10% | -$452K | 0.02% | 575 |
|
|
2024
Q4 | $3.08M | Buy |
36,822
+1,149
| +3% | +$94.4K | 0.01% | 756 |
|
|
2024
Q3 | $2.61M | Buy |
35,673
+223
| +0.6% | +$16.8K | 0.01% | 833 |
|
|
2024
Q2 | $2.43M | Sell |
35,450
-16,972
| -32% | -$1.18M | 0.01% | 837 |
|
|
2024
Q1 | $3.63M | Hold |
52,422
| – | – | 0.01% | 872 |
|
|
2023
Q4 | $3.75M | Hold |
52,422
| – | – | 0.01% | 802 |
|
|
2023
Q3 | $2.73M | Sell |
52,422
-3,009
| -5% | -$175K | 0.01% | 921 |
|
|
2023
Q2 | $3.51M | Hold |
55,431
| – | – | 0.01% | 804 |
|
|
2023
Q1 | $3M | Hold |
55,431
| – | – | 0.01% | 866 |
|
|
2022
Q4 | $2.93M | Buy |
55,431
+2,421
| +5% | +$121K | 0.01% | 868 |
|
|
2022
Q3 | $2.47M | Hold |
53,010
| – | – | 0.01% | 948 |
|
|
2022
Q2 | $3.03M | Hold |
53,010
| – | – | 0.01% | 846 |
|
|
2022
Q1 | $3.24M | Sell |
53,010
-16,718
| -24% | -$868K | 0.01% | 942 |
|
|
2021
Q4 | $3.65M | Sell |
69,728
-21,944
| -24% | -$922K | 0.01% | 903 |
|
|
2021
Q3 | $3.42M | Buy |
91,672
+25,086
| +38% | +$872K | 0.01% | 939 |
|
|
2021
Q2 | $2.72M | Buy |
66,586
+2,843
| +4% | +$105K | 0.01% | 1204 |
|
|
2021
Q1 | $2.16M | Sell |
63,743
-18,390
| -22% | -$638K | 0.01% | 1513 |
|
|
2020
Q4 | $2.61M | Buy |
+82,133
| New | +$2.16M | 0.01% | 1261 |
|
|
2020
Q3 | – | Sell |
-83,840
| Closed | -$2.15M | – | 1645 |
|
|
2020
Q2 | $2.15M | Buy |
+83,840
| New | +$1.7M | 0.01% | 1282 |
|
|
2017
Q3 | – | Sell |
-62,500
| Closed | -$776K | – | 966 |
|
|
2017
Q2 | $776K | Hold |
62,500
| – | – | ﹤0.01% | 851 |
|
|
2017
Q1 | $1.02M | Hold |
62,500
| – | – | ﹤0.01% | 829 |
|
|
2016
Q4 | $943K | Hold |
62,500
| – | – | ﹤0.01% | 828 |
|
|
2016
Q3 | $953K | Hold |
62,500
| – | – | ﹤0.01% | 826 |
|
|
2016
Q2 | $2.43M | Hold |
62,500
| – | – | 0.01% | 688 |
|
|
2016
Q1 | $1.74M | Hold |
62,500
| – | – | 0.01% | 733 |
|
|
2015
Q4 | $3.36M | Hold |
62,500
| – | – | 0.01% | 637 |
|
|
2015
Q3 | $2.5M | Buy |
62,500
+17,500
| +39% | +$571K | 0.01% | 701 |
|
|
2015
Q2 | $1.44M | Hold |
45,000
| – | – | 0.01% | 801 |
|
|
2015
Q1 | $1.07M | Hold |
45,000
| – | – | ﹤0.01% | 846 |
|
|
2014
Q4 | $794K | Hold |
45,000
| – | – | ﹤0.01% | 892 |
|
|
2014
Q3 | $617K | Hold |
45,000
| – | – | ﹤0.01% | 880 |
|
|
2014
Q2 | $759K | Buy |
+45,000
| New | +$744K | ﹤0.01% | 865 |
|
Other funds holding ITCI
KIM
HNB
State of New Jersey Common Pension Fund D's ITCI Position: Q2 2025 in Review
State of New Jersey Common Pension Fund D sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 33,199 shares — an estimated $4.38M sold.
State of New Jersey Common Pension Fund D first reported a position in ITCI in Q2 2014 and held it in 32 quarters. The position peaked at $4.38M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.
- State of New Jersey Common Pension Fund D reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
- State of New Jersey Common Pension Fund D sold 33,199 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $4.38M.
- State of New Jersey Common Pension Fund D first reported a position in Intra-Cellular Therapies Inc. in Q2 2014 and held it in 32 quarters.
- State of New Jersey Common Pension Fund D's Intra-Cellular Therapies Inc. position peaked at $4.38M in Q1 2025.
- 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.
Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2025, filed 31 Jul 2025.